Neurobehavioral Research Inc /ID# 232791 — Cedarhurst, New York

Neurobehavioral Research Inc /ID# 232791 is a clinical research site located in Cedarhurst, New York, United States 11516.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Neurobehavioral Research Inc /ID# 232791 has participated in 1 clinical trials.

Therapeutic areas: Bipolar I Disorder, Mania, Depression.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cedarhurst

Browse all research sites in New York · View every site in Cedarhurst

• Neurobehavioral Research
• Research Site
• Five Towns Neuroscience Research
• Clinical Site
• Neurocrine Clinical Site
• Investigational Site
• Cedarhurst
• Pfizer Investigational Site
• Teva Investigational Site 14772
• Otsuka Investigational Site
• Novartis Investigative Site
• Neumora Investigator Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Neurobehavioral Research Inc /ID# 232791?

Neurobehavioral Research Inc /ID# 232791 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Neurobehavioral Research Inc /ID# 232791 conducted?

Neurobehavioral Research Inc /ID# 232791 has 1 clinical trials on record. Their work covers Bipolar I Disorder, Mania, Depression.

Is Neurobehavioral Research Inc /ID# 232791 accredited by Crixeo Clinical Trials?

Neurobehavioral Research Inc /ID# 232791 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Neurobehavioral Research Inc /ID# 232791?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.